Key Benefits
-
Accelerated Lot Release
Co-located manufacturing and QC dramatically shorten timelines compared to outsourced models. -
Regulatory Readiness
All assays are qualified or validated per ICH Q2(R1), supporting IND/BLA submissions with robust data packages. -
Comprehensive CQA Coverage
From compendial safety tests to advanced capsid analytics, we address every Critical Quality Attribute (CQA) required for human administration.
Our Release Testing Panel
-
Safety & Compendial Testing
Ensuring Patient Safety
We adhere to pharmacopeial standards (USP/EP/JP) for mandatory safety testing:- Sterility (USP <71>)
- Endotoxin (USP <85>)
- Mycoplasma (USP <63>)
Developing a custom safety assay? Visit Analytical Development.
-
Potency & Titer Quantification
-
Product Purity & Characterization
-
Identity & Genomic Integrity
Related Service
Resource
REQUEST A QUOTE
Confidentiality Commitment from PackGene:
The information you submit here will be kept strictly confidential. Packgene will not disclose to any third party or related personnel, and it will only be used for project evaluation and progress reports according to the requests from submitter under confidentiality conditions.